Rank 94 • AI & Clinical Intelligence
Koios Medical
Develops FDA-cleared smart ultrasound AI software that analyzes thyroid and breast lesions to improve cancer diagnostic accuracy.
Visit website- Signal Score
- 80.9
- Total raised
- $15M
- Stage
- Series B
- Founded
- 2012
- Headquarters
- Chicago, United States
- Region
- North America
Their signal
By using AI to interpret ultrasound scans in real time, Koios reduces unnecessary biopsies and provides immediate diagnostic support to radiologists.
Signal Score 80.9editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.